Based on pre-clinical data positively correlating Pax-8 (Paired box-8) and NIS promotor activity [53], along with the observation that PAX8-PPARγ translocations are present in 35% of FTC. Here, PPARG is linked to thyroid cancer, nonmedullary, 2.